Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone in high-risk prostate cancer
NCT00004124Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1999
- Primary completion
- Aug 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of mitoxantrone in prostate cancer (PCa), sponsored by SWOG Cancer Research Network. Started Oct 1999; status: completed.
02
Drugs
mitoxantrone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004124.